Literature DB >> 26769333

Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication.

Elizabeth B de Sousa Fernandes Perna1, Eef L Theunissen1, Kim P C Kuypers1, Elisabeth A Evers1, Peter Stiers1, Stefan W Toennes2, Jurriaan Witteman3, Wim van Dalen3, Johannes G Ramaekers1.   

Abstract

Drugs of abuse stimulate striatal dopamine release and activate reward pathways. This study examined the impact of alcohol and cannabis marketing on the reward circuit in alcohol and cannabis users while sober and intoxicated. It was predicted that alcohol and cannabis marketing would increase striatal activation when sober and that reward sensitivity would be less during alcohol and cannabis intoxication. Heavy alcohol (n = 20) and regular cannabis users (n = 21) participated in a mixed factorial study involving administration of alcohol and placebo in the alcohol group and cannabis and placebo in the cannabis group. Non-drug users (n = 20) served as between group reference. Brain activation after exposure to alcohol and cannabis marketing movies was measured using functional magnetic resonance imaging and compared between groups while sober and compared with placebo while intoxicated. Implicit alcohol and cannabis cognitions were assessed by means of a single-category implicit association test. Alcohol and cannabis marketing significantly increased striatal BOLD activation across all groups while sober. Striatal activation however decreased during intoxication with alcohol and cannabis. Implicit associations with cannabis marketing cues were significantly more positive in alcohol and cannabis users as compared with non-drug using controls. Public advertising of alcohol or cannabis use elicits striatal activation in the brain's reward circuit. Reduction of marketing would reduce brain exposure to reward cues that motivate substance use. Conversely, elevated dopamine levels protect against the reinforcing potential of marketing.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  alcohol; cannabis; craving; cue-reactivity; fmri; marketing

Mesh:

Year:  2016        PMID: 26769333     DOI: 10.1111/adb.12351

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  10 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

Review 2.  Evidence for incentive salience sensitization as a pathway to alcohol use disorder.

Authors:  Roberto U Cofresí; Bruce D Bartholow; Thomas M Piasecki
Journal:  Neurosci Biobehav Rev       Date:  2019-10-28       Impact factor: 8.989

3.  Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Authors:  Sarah D Lichenstein; Nick Manco; Lora M Cope; Leslie Egbo; Kathleen A Garrison; Jillian Hardee; Ansel T Hillmer; Kristen Reeder; Elisa F Stern; Patrick Worhunsky; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

4.  The Neurobiological Mechanism of Chemical Aversion (Emetic) Therapy for Alcohol Use Disorder: An fMRI Study.

Authors:  Ralph L Elkins; Todd L Richards; Robert Nielsen; Richard Repass; Henriettae Stahlbrandt; Hunter G Hoffman
Journal:  Front Behav Neurosci       Date:  2017-09-28       Impact factor: 3.558

5.  Alcohol use disorders, beverage preferences and the influence of alcohol marketing: a preliminary study.

Authors:  Morgane Guillou Landreat; Céline Beauvais; Marie Grall Bronnec; Delphine Le Goff; Jean Yves Le Reste; Delphine Lever; Antoine Dany; Karine Gallopel Morvan
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-11-30

Review 6.  A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.

Authors:  Lani Cupo; Eric Plitman; Elisa Guma; M Mallar Chakravarty
Journal:  Transl Psychiatry       Date:  2021-04-13       Impact factor: 6.222

7.  Cannabis Use and Neuroadaptation: A Call for Δ 9 -Tetrahydrocannabinol Challenge Studies.

Authors:  Johannes G Ramaekers; Eef L Theunissen; Peter van Ruitenbeek; Natasha L Mason
Journal:  Front Psychiatry       Date:  2022-04-14       Impact factor: 5.435

8.  Impact of alcohol marketing on drinkers with Alcohol use disorders seeking treatment: a mixed-method study protocol.

Authors:  Morgane Guillou-Landreat; Antoine Dany; Jean Yves Le Reste; Delphine Le Goff; Amine Benyamina; Marie Grall-Bronnec; Karine Gallopel-Morvan
Journal:  BMC Public Health       Date:  2020-04-07       Impact factor: 3.295

9.  Unraveling the role of cigarette use in neural cannabis cue reactivity in heavy cannabis users.

Authors:  Lauren Kuhns; Emese Kroon; Francesca Filbey; Janna Cousijn
Journal:  Addict Biol       Date:  2020-08-05       Impact factor: 4.280

Review 10.  Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies.

Authors:  Hannah Sehl; Gill Terrett; Lisa-Marie Greenwood; Magdalena Kowalczyk; Hannah Thomson; Govinda Poudel; Victoria Manning; Valentina Lorenzetti
Journal:  Psychopharmacology (Berl)       Date:  2021-09-10       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.